<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04174534</url>
  </required_header>
  <id_info>
    <org_study_id>P54_CLD004</org_study_id>
    <nct_id>NCT04174534</nct_id>
  </id_info>
  <brief_title>ROMEO®2 PAD. 2 YEARS PROSPECTIVE FOLLOW-UP</brief_title>
  <acronym>ROMEO 2 PAD FR</acronym>
  <official_title>DEGENERATIVE DISC DISEASE TREATED BY DECOMPRESSION AND ARTHRODESIS USING A PEEK-TITANIUM POLYAXIAL INTERSPINOUS POSTERIOR FUSION DEVICE: ROMEO®2 PAD. 2 YEARS PROSPECTIVE FOLLOW-UP</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Spineart SA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Spineart SA</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed as a post-marketing observational, controlled, prospective,&#xD;
      non-inferiority study where the efficacy and safety of the Degenerative Disc Disease&#xD;
      treatment by arthrodesis using PEEK(PolyEtherEtherKetone)-Titanium polyaxial interspinous&#xD;
      posterior fusion device ROMEO®2 PAD will be compared to the gold standard treatment by&#xD;
      instrumented circumferential arthrodesis.&#xD;
&#xD;
      The primary study aim is to evaluate functional improvement at 1 and 2 years after surgery.&#xD;
      The fusion at 1 year and 2 years post-surgery, the short and long- term clinical and&#xD;
      neurological success and patient related health status satisfaction will also be evaluated.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Lumbar spine fusion is the gold standard technique for the treatment of low-back pain due to&#xD;
      various spinal pathologies mostly related to degenerative conditions. Pedicle-screws&#xD;
      constructs are widely used to achieve a strong fixation but may be associated with potential&#xD;
      complications.&#xD;
&#xD;
      ROMEO® 2 PAD is composed of two polyaxial titanium teethed plates to adapt to anatomical&#xD;
      variations, one step locking mechanism and a radiolucent polymer cylinder.&#xD;
&#xD;
      The ROMEO®2 PAD is a posterior non pedicle supplemental fixation device intended for use in&#xD;
      combination with an inter-somatic device, to achieve fusion at single or multilevel in the&#xD;
      lumbar spine (L1-S1 inclusive). A range of six heights (from 8 to 18mm) are designed to fit&#xD;
      anatomical variations. It is intended for plate fixation to the spinous process for the&#xD;
      purpose of achieving spinal fixation.&#xD;
&#xD;
      The main objective of the study is the evaluation of functional improvement as measured by&#xD;
      changes in Oswestry Disability Index (ODI) at 12 and 24 months after surgery, respectively.&#xD;
&#xD;
      The secondary objectives are:&#xD;
&#xD;
        -  Evaluation of fusion rate at 12 and 24 months after surgery, respectively, based on CT&#xD;
           scans.&#xD;
&#xD;
        -  Evaluation of mobility at the treated level at 12 and 24 months after surgery,&#xD;
           respectively, based on ROM (Range of motion) assessed using dynamic lumbar&#xD;
           flexion-extension radiography.&#xD;
&#xD;
        -  Evaluation of functional capacities post-surgery, as measured by ODI. Comparison between&#xD;
           preoperative status and controls at 6 weeks, 6 months after surgery, respectively.&#xD;
&#xD;
        -  Evaluation of Health-related Quality of Life (HR-QOL) improvement and patient&#xD;
           satisfaction, as measured by SF-36 (Short Form 36) scores, the physical (PCS) and mental&#xD;
           (MCS) components; comparison between preoperative status and controls at 6 weeks, 6, at&#xD;
           12 and 24 months after surgery, respectively.&#xD;
&#xD;
        -  Evaluation of low back and legs pain as measured by Visual Analogue Scale (VAS) (changes&#xD;
           in VAS scores): comparison between preoperative status and controls at 6 weeks, 6, 12&#xD;
           and 24 months after surgery, respectively.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Weak enrollment rate and sanitary situation&#xD;
  </why_stopped>
  <start_date type="Actual">October 11, 2019</start_date>
  <completion_date type="Actual">November 11, 2020</completion_date>
  <primary_completion_date type="Actual">November 11, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>ODI</measure>
    <time_frame>24 months</time_frame>
    <description>Absolute change in ODI at 12 and 24 months post-operative compared to baseline (pre-operative status)</description>
  </primary_outcome>
  <enrollment type="Actual">3</enrollment>
  <condition>Spinal Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Skeletally mature patients with stenosis and Grade I degenerative spondylolisthesis,&#xD;
        secondary to lumbar degenerative disc disease, indicated for treatment with Romeo 2 PAD at&#xD;
        one level between L1 and S1.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Surgical treatment of stenosis and Grade I degenerative spondylolisthesis, secondary to&#xD;
        lumbar degenerative disc disease at one level between L1 and L5 in skeletally mature&#xD;
        patients&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Vertebral traumatic lesions including dislocation;&#xD;
&#xD;
          -  Insufficient vertebral body bone quality;&#xD;
&#xD;
          -  Severe osteoporosis;&#xD;
&#xD;
          -  Bone tumor in the region of the implant;&#xD;
&#xD;
          -  Spondylolysis;&#xD;
&#xD;
          -  Lytic spondylolisthesis;&#xD;
&#xD;
          -  Degenerative spondylolisthesis Grade II or more;&#xD;
&#xD;
          -  Mental illness or inadequate patient activity;&#xD;
&#xD;
          -  Infection;&#xD;
&#xD;
          -  Vascular disorders or illness;&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dervilla Bermingham, MSc</last_name>
    <role>Study Director</role>
    <affiliation>Spineart SA</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital de la Timone</name>
      <address>
        <city>Marseille</city>
        <zip>13005</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Gui de Chauliac</name>
      <address>
        <city>Montpellier</city>
        <zip>34000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique St Jean</name>
      <address>
        <city>Montpellier</city>
        <zip>34093</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>November 21, 2019</study_first_submitted>
  <study_first_submitted_qc>November 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 22, 2019</study_first_posted>
  <last_update_submitted>March 17, 2021</last_update_submitted>
  <last_update_submitted_qc>March 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

